The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
FOX 9 Minneapolis-St. Paul on MSN1d
FTC says Optum, other prescription benefit managers inflate cancer drug prices 1,000%Prescription benefit managers have been under growing scrutiny from state and federal regulators who have accused them of ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
WQRF Rockford on MSN18h
Synders Pharmacy in Oregon closes drive-thru, says it can’t afford staffingSnyders Pharmacy, located in Oregon’s Ace Hardware, announced it has suspended operation of its drive-thru due to lack of ...
The plaintiffs argue federal law lets employers structure medicine benefits in ways the 2019 state law threatens.
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
A report from the Federal Trade Commission (FTC) has determined that pharmacy benefit managers (PBMs) are linked to significant cost increases for cancer, HIV, and other critical specialty drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback